Disruptive Mood Dysregulation Disorder (DMDD): Background, Pharmacological and NonPharmacological Treatment Options presented by Saundra Stock, MD on March 15, 2017.
In this webinar recording, Dr. Saundra Stock reviewed Disruptive Mood Dysregulation Disorder (DMDD) as a new diagnosis in the DSM5, including: presentation, pharmacological and nonpharmacological treatment options.
For more information on our Program, electronic copies of our best practice psychotherapeutic medication guidelines, and other resources visit our website http://floridabhcenter.org/.